Reviva Pharmaceuticals Holdings Inc (RVPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RVPH Annual Balance Sheets →
The data below summarizes Reviva Pharmaceuticals Holdings Inc's balance sheet position from Mar 31 2025 to Mar 31 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent22.19
Cash & Short-term Investments22.00
Other Current Assets0.82
Prepaid Expense And Other Assets Current0.55
Total Current Assets23.56
Other Assets, Noncurrent0.00
Prepaid Clinical Trial Costs0.82
Prepaid Clinical Trial Costs Noncurrent-
Total Assets23.56
Liabilities
Accounts Payable, Current AC2.09
Employee-related Liabilities, Current AC0.41
Short-term Debt DE10.23
Other Liabilities, Current3.39
Total Current Liabilities6.12
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.00
Accrued Clinical Expenses2.68
Total Liabilities6.12
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock204.76
Retained Earnings / Accumulated Deficit-187.33
Other Equity0.00
Common Stockholder's Equity17.44
Total Stockholder's Equity17.44
Liabilities & Stockholder's Equity23.56
4 historic quarters locked

Sign in to unlock the full Reviva Pharmaceuticals Holdings Inc balance sheet history.

About Reviva Pharmaceuticals Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-027358

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License